Page last updated: 2024-10-24

protein autoubiquitination

Definition

Target type: biologicalprocess

The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink. [GOC:ai]

Protein autoubiquitination is a fundamental cellular process where a protein directly adds ubiquitin molecules to itself. Ubiquitin is a small, highly conserved protein that acts as a molecular tag, directing proteins to various cellular destinations and influencing their fate. This process plays a crucial role in regulating a diverse range of cellular processes, including:

* **Protein Degradation:** Ubiquitination can target proteins for degradation by the proteasome, a cellular machinery that breaks down unwanted or damaged proteins.
* **Signal Transduction:** Autoubiquitination can alter protein activity and stability, impacting downstream signaling pathways.
* **DNA Repair:** Autoubiquitination is involved in the recruitment and activation of DNA repair enzymes, ensuring genomic integrity.
* **Cell Cycle Control:** This process regulates the progression of the cell cycle, ensuring proper DNA replication and cell division.

**Mechanism of Autoubiquitination:**

The process of autoubiquitination involves a series of steps:

1. **Activation:** The ubiquitin molecule is activated by an E1 ubiquitin-activating enzyme, forming a high-energy thioester bond.
2. **Conjugation:** The activated ubiquitin is transferred to an E2 ubiquitin-conjugating enzyme, which acts as an intermediary.
3. **Ligation:** The E2 enzyme interacts with an E3 ubiquitin ligase, which specifically recognizes and binds to the target protein. The E3 ligase facilitates the transfer of ubiquitin from the E2 to the target protein.

**Types of Autoubiquitination:**

There are various types of ubiquitination, including:

* **Mono-ubiquitination:** A single ubiquitin molecule is attached to the target protein.
* **Poly-ubiquitination:** Multiple ubiquitin molecules are linked together, forming a ubiquitin chain.
* **Multi-mono-ubiquitination:** Several ubiquitin molecules are attached to different lysine residues on the target protein.

The specific type of ubiquitin chain and its linkage determine the fate of the target protein.

**Regulation of Autoubiquitination:**

Autoubiquitination is tightly regulated to ensure proper cellular function. This regulation involves:

* **Substrate Specificity:** E3 ligases have distinct substrate preferences, ensuring that specific proteins are targeted for ubiquitination.
* **Post-translational Modifications:** Various modifications, such as phosphorylation, acetylation, and methylation, can influence autoubiquitination.
* **Ubiquitin Binding Proteins:** Proteins that bind to ubiquitin can modulate the activity of ubiquitin ligases or target proteins.

**Dysregulation of Autoubiquitination:**

Aberrant autoubiquitination is linked to various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases.

**Conclusion:**

Protein autoubiquitination is a highly complex and essential cellular process that regulates a broad range of cellular functions. Understanding the intricate mechanisms of autoubiquitination is crucial for deciphering the underlying causes of various diseases and developing targeted therapeutic strategies.'
"

Proteins (3)

ProteinDefinitionTaxonomy
E3 ubiquitin-protein ligase UHRF1An E3 ubiquitin-protein ligase UHRF1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96T88]Homo sapiens (human)
E3 ubiquitin-protein ligase Mdm2An E3 ubiquitin-protein ligase Mdm2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q00987]Homo sapiens (human)
Breast cancer type 1 susceptibility proteinA breast cancer type 1 susceptibility protein that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)

Compounds (22)

CompoundDefinitionClassesRoles
catecholcatecholsallelochemical;
genotoxin;
plant metabolite
gossypolGossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
beta-thujaplicinbeta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

beta-thujaplicin: structure
cyclic ketone;
enol;
monoterpenoid
antibacterial agent;
antifungal agent;
antineoplastic agent;
antiplasmodial drug;
plant metabolite
quinone1,4-benzoquinone : The simplest member of the class of 1,4-benzoquinones, obtained by the formal oxidation of hydroquinone to the corresponding diketone. It is a metabolite of benzene.

benzoquinone : The simplest members of the class of benzoquinones, consisting of cyclohexadiene which is substituted by two oxo groups.

quinone : Compounds having a fully conjugated cyclic dione structure, such as that of benzoquinones, derived from aromatic compounds by conversion of an even number of -CH= groups into -C(=O)- groups with any necessary rearrangement of double bonds (polycyclic and heterocyclic analogues are included).
1,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
vorinostatvorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
dicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
apomorphineApomorphine: A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use.aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
cytarabinebeta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside
antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
nutlin 3stilbenoid
nutlin 2
nutlin 1nutlin 1: an MDM2 antagonist; structure in first source
nutlin-3anutlin 3: an MDM2 antagonist; structure in first sourcestilbenoid
MI-63MI-63 : An azaspiro compound resulting from the formal fusion of position 3 of 6-chloro-oxindole with position 3 of (2R,3SS5S)-3-(3-chloro-2-fluorophenyl)-5-(2,2-dimethylpropyl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-2-carboxamide. It is a potent inhibitor of the MDM2-p53 interaction.azaspiro compound;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
oxindoles;
pyrrolidines;
secondary carboxamide
apoptosis inducer
nutlin-3bNutlin;
piperazinone
anticoronaviral agent
pb 12
(5-bromo-3-pyridinyl)-[4-(1-pyrrolidinyl)-1-piperidinyl]methanonearomatic carboxylic acid;
pyridinemonocarboxylic acid
spautin-1
nvp-cgm097NVP-CGM097: an MDM2 and HDM2 inhibitor; structure in first source
rg7388RG7388: structure in first source
sar405838SAR405838: an inhibitor of the interaction of MDM2 and p53; has antineoplastic activity; structure in first source
entecavirbenzamides;
N-acylpiperidine
rg7112
amg 232